(Q42180828)

18 October 2017

Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea (English)

1 reference

18 October 2017

0 references

Clostridium difficile

object named as

Clostridium difficile

1 reference

2

Dale N Gerding

1 reference

18 October 2017

Stuart Johnson

1

1 reference

18 October 2017

Thomas J Louie

series ordinal

3

1 reference

18 October 2017

Nancy M Ruiz

series ordinal

4

1 reference

18 October 2017

Sherwood L Gorbach

series ordinal

5

1 reference

18 October 2017

language of work or name

English

0 references

publication date

21 May 2012

1 reference

Antimicrobial Agents and Chemotherapy

18 October 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

18 October 2017

56

1 reference

18 October 2017

8

1 reference

18 October 2017

4043-4045

1 reference

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Clostridium difficile mixed infection and reinfection

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Relapse versus reinfection: surveillance of Clostridium difficile infection

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Fidaxomicin versus vancomycin for Clostridium difficile infection

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Clostridium difficile infection: epidemiology, risk factors and management

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Nitazoxanide for the treatment of Clostridium difficile colitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3421600

Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22615287

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22615287

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00605-12

1 reference

18 October 2017

1 reference

18 October 2017

PubMed publication ID

22615287

1 reference